Aura Biosciences, Inc.
AURA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $1,295 | $0 | $0 |
| Gross Profit | $0 | -$1,295 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $73,302 | $63,937 | $42,238 | $25,161 |
| G&A Expenses | $22,814 | $19,759 | $18,057 | $10,089 |
| SG&A Expenses | $22,814 | $19,759 | $18,057 | $10,089 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $96,116 | $83,696 | $60,295 | $35,250 |
| Operating Income | -$96,116 | -$84,991 | -$60,295 | -$35,250 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $9,309 | $8,720 | $1,532 | -$1 |
| Pre-Tax Income | -$86,807 | -$76,271 | -$58,763 | -$35,251 |
| Tax Expense | $112 | $137 | $0 | $0 |
| Net Income | -$86,919 | -$76,408 | -$58,763 | -$35,251 |
| % Margin | – | – | – | – |
| EPS | -1.75 | -1.93 | -1.96 | -1.58 |
| % Growth | 9.3% | 1.5% | -24.1% | – |
| EPS Diluted | -1.75 | -1.93 | -1.96 | -1.58 |
| Weighted Avg Shares Out | 49,650 | 39,620 | 29,937 | 29,212 |
| Weighted Avg Shares Out Dil | 49,650 | 39,620 | 29,937 | 29,212 |
| Supplemental Information | – | – | – | – |
| Interest Income | $9,429 | $8,588 | $1,864 | $13 |
| Interest Expense | $0 | $0 | $0 | $13 |
| Depreciation & Amortization | $1,223 | $1,295 | $1,177 | $831 |
| EBITDA | -$94,893 | -$83,696 | -$59,118 | -$34,419 |
| % Margin | – | – | – | – |